Literature DB >> 28457238

Arrhythmias in Patients with Atrial Defects.

Tahmeed Contractor1, Ravi Mandapati2.   

Abstract

Atrial arrhythmias are common in patients with atrial septal defects. A myriad of factors are responsible for these that include remodeling related to the defect and scar created by the repair or closure. An understanding of potential arrhythmias, along with entrainment and high-density activation mapping can result in accurate diagnosis and successful ablation. Atrial fibrillation is being seen increasingly after patent foramen ovale closure and may be the primary etiology of recurrent stroke in these patients.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrial arrhythmia; Atrial fibrillation; Atrial septal defect; Patent foramen ovale

Mesh:

Year:  2017        PMID: 28457238     DOI: 10.1016/j.ccep.2017.02.006

Source DB:  PubMed          Journal:  Card Electrophysiol Clin        ISSN: 1877-9182


  4 in total

1.  Comparison of Figulla Flex® and Amplatzer™ devices for atrial septal defect closure: A meta-analysis.

Authors:  Alvaro Aparisi; Roman J Arnold; Hipólito Gutiérrez; Ana Revilla; Ana Serrador; Benigno Ramos; Tania Rodriguez-Gabella; Alberto Campo; Carlos Baladrón; Itziar Gómez; Manuel Carrasco-Moraleja; José A San Roman; Ignacio J Amat-Santos
Journal:  Cardiol J       Date:  2020-04-24       Impact factor: 2.737

2.  Right atrial function by speckle tracking echocardiography in atrial septal defect: Prediction of atrial fibrillation.

Authors:  Antonio Vitarelli; Enrico Mangieri; Carlo Gaudio; Gaetano Tanzilli; Fabio Miraldi; Lidia Capotosto
Journal:  Clin Cardiol       Date:  2018-10-16       Impact factor: 2.882

Review 3.  Effect of maternal pregestational diabetes mellitus on congenital heart diseases.

Authors:  Zhi-Yan Chen; Shuang-Fa Mao; Ling-Hong Guo; Jian Qin; Li-Xin Yang; Yin Liu
Journal:  World J Pediatr       Date:  2022-07-15       Impact factor: 9.186

Review 4.  Atrial septal defect (ASD) device trans-catheter closure: limitations.

Authors:  Alessia Faccini; Gianfranco Butera
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.